New insights into factors that may predict, increase or protect against the impact of COVID-19 and the pandemic on memory and thinking skills were revealed by multiple studies reported today at the Alzheimer’s Association International Conference 2022 in San Diego and virtually.
Monthly Archives: July 2022
Alzheimer’s disease blood biomarkers (BBMs) may revolutionize the diagnosis of Alzheimer’s in the future, but are not yet ready for widespread use, according to a newly-published article by leading international clinicians and researchers convened by the Alzheimer’s Association.
Researchers compare the antimicrobial activity of hemp seed oil and tea tree oil products against pathogenic bacteria.
Researchers review current developments in preclinical studies associated with recombinant ACE2 decoy receptors against coronaviruses.
Researchers summarize the toxic effects of nanoparticles on macrophages in vitro.
A new study discusses the utility of CBD in treating the inflammatory symptoms of COVID-19
Traumatic brain injuries (TBIs) are usually diagnosed with MRI and computed tomography scans, but these techniques often miss more mild damage.
New research published in JASN reveals profound sex differences in the detection, monitoring, and management of chronic kidney disease (CKD) in Sweden.
As seen with the COVID-19 pandemic, detection methods that are rapid, simple, accurate, and sensitive are vital for detecting viral pathogens and for controlling the spread of infectious diseases.
Australian scientists are making strides towards solving one of the greatest mysteries of the universe: the nature of invisible dark matter. The ORGAN Experiment, Australia’s first major dark matter detector, recently completed a search for a hypothetical particle called an axion—a popular candidate among theories that try to explain dark matter. ORGAN has placed new […]